Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,624 | 512 | 98.7% |
| Education | $97.84 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,024 | 59 | $0 (2024) |
| PFIZER INC. | $961.28 | 94 | $0 (2024) |
| Amgen Inc. | $878.56 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $842.70 | 52 | $0 (2024) |
| Allergan Inc. | $558.02 | 38 | $0 (2019) |
| GlaxoSmithKline, LLC. | $506.16 | 41 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $391.84 | 28 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $364.89 | 30 | $0 (2020) |
| Novo Nordisk Inc | $352.33 | 29 | $0 (2023) |
| Lilly USA, LLC | $339.28 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.11 | 8 | Amgen Inc. ($107.70) |
| 2023 | $606.51 | 32 | PFIZER INC. ($139.07) |
| 2022 | $300.52 | 10 | Progenics Pharmaceuticals, Inc. ($116.16) |
| 2021 | $82.14 | 3 | PFIZER INC. ($69.27) |
| 2020 | $364.90 | 20 | Amgen Inc. ($61.97) |
| 2019 | $2,168 | 157 | Amgen Inc. ($316.39) |
| 2018 | $2,028 | 142 | AstraZeneca Pharmaceuticals LP ($340.12) |
| 2017 | $1,929 | 149 | AstraZeneca Pharmaceuticals LP ($375.67) |
All Payment Transactions
521 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $107.70 | General |
| Category: Bone Health | ||||||
| 10/28/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: HIV | ||||||
| 04/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PAIN | ||||||
| 03/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 02/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Respiratory | ||||||
| 02/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: VACCINES | ||||||
| 10/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: PAIN | ||||||
| 10/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: PAIN | ||||||
| 10/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardio-renal | ||||||
| 09/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.68 | General |
| 08/30/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: VACCINES | ||||||
| 08/18/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: PAIN | ||||||
| 08/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.56 | General |
| 08/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardio-renal | ||||||
| 08/03/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Genetic Disease | ||||||
| 08/02/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Hematology | ||||||
| 08/01/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: VACCINES | ||||||
| 07/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Diabetes | ||||||
| 07/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Biological | ||||||
| 07/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,448 | 3,820 | $493,827 | $179,866 |
| 2022 | 19 | 1,265 | 3,306 | $412,448 | $149,733 |
| 2021 | 22 | 1,105 | 3,080 | $239,624 | $121,292 |
| 2020 | 23 | 1,283 | 3,090 | $251,380 | $118,780 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 367 | 565 | $194,925 | $53,879 | 27.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 20 | 1,981 | $67,354 | $35,900 | 53.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 88 | 88 | $49,896 | $24,788 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 276 | 350 | $85,750 | $22,654 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 84 | 84 | $29,736 | $11,793 | 39.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 143 | 143 | $19,019 | $10,841 | 57.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 34 | $16,490 | $4,908 | 29.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 155 | 156 | $4,680 | $4,586 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 100 | 100 | $3,000 | $2,940 | 98.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,716 | $1,570 | 91.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 118 | $4,602 | $1,326 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 26 | $4,004 | $1,211 | 30.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 15 | $3,675 | $1,151 | 31.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 14 | $2,655 | $681.90 | 25.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 16 | 16 | $2,448 | $653.63 | 26.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $1,728 | $505.45 | 29.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 27 | $1,053 | $342.09 | 32.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 28 | $280.00 | $95.48 | 34.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 51 | $816.00 | $40.61 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 452 | $155,940 | $42,467 | 27.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 1,740 | $59,160 | $29,180 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 275 | 345 | $84,525 | $24,570 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $32,214 | $13,245 | 41.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 34 | 34 | $19,278 | $9,476 | 49.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 120 | 121 | $7,865 | $7,714 | 98.1% |
About Dr. Leo Smith, MD
Dr. Leo Smith, MD is a Family Medicine healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1023265816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leo Smith, MD has received a total of $7,722 in payments from pharmaceutical and medical device companies, with $242.11 received in 2024. These payments were reported across 521 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,624).
As a Medicare-enrolled provider, Smith has provided services to 5,101 Medicare beneficiaries, totaling 13,296 services with total Medicare billing of $569,671. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Santa Rosa, CA
- Active Since 08/22/2008
- Last Updated 11/26/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023265816
Products in Payments
- FARXIGA (Drug) $532.35
- EVENITY (Biological) $383.06
- JARDIANCE (Drug) $382.06
- VRAYLAR (Drug) $367.42
- Prolia (Biological) $300.97
- XARELTO (Drug) $293.38
- STIOLTO RESPIMAT (Drug) $261.82
- SYMBICORT (Drug) $238.70
- ANORO (Drug) $225.97
- PREVNAR - 13 (Biological) $196.02
- TRULICITY (Drug) $180.17
- TRELEGY ELLIPTA (Drug) $169.35
- AJOVY (Drug) $169.02
- CHANTIX (Drug) $149.22
- BEVESPI AEROSPHERE (Drug) $138.39
- PREVNAR 20 (Biological) $122.19
- LYRICA (Drug) $117.78
- PYLARIFY (Drug) $116.16
- EUCRISA (Drug) $112.58
- Myrbetriq (Drug) $106.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Santa Rosa
Dora Martinez, M.d, M.D
Family Medicine — Payments: $293,315
Dr. Amy Shaw, Md, MD
Family Medicine — Payments: $112,442
Dr. Marisha Chilcott, M.d, M.D
Family Medicine — Payments: $40,447
Johnathan Nguyen
Family Medicine — Payments: $10,780
Dr. Stephen Crane, Md, MD
Family Medicine — Payments: $6,228
Dr. David Dellalana, Md, MD
Family Medicine — Payments: $2,301